Latest / Becker’s Healthcare Podcast / Introducing Interra Health: A New Era of Medication Access

Transcript

Introducing Interra Health: A New Era of Medication Access · Becker’s Healthcare Podcast

• 0:00
  Welcome everybody to Becker's Healthcare Podcast.
• 0:03
  I'm Rich Zane, chief medical officer and chief
• 0:05
  innovation officer at UCHealth in Colorado.
• 0:09
  Today's prescribing journey is more complex than ever,
• 0:12
  with health systems navigating rising costs, fragmented data,
• 0:16
  growing expectations for transparency from both providers and
• 0:19
  patients,
• 0:20
  not to mention the crushing administrative and regulatory
• 0:23
  burden. Too often,
• 0:25
  the breakdown between prescribing
• 0:27
  and prescription fulfillment creates friction that impacts access,
• 0:31
  adherence,
• 0:32
  provider satisfaction,
• 0:34
  pharmacy performance,
• 0:35
  and patient outcomes.
• 0:37
  In today's conversation, we'll explore where those breakdowns
• 0:40
  most often occur
• 0:42
  and how trusted real time data intelligence
• 0:45
  and connected workflows can support more confident prescribing
• 0:48
  decisions,
• 0:49
  improve patient access and affordability,
• 0:51
  and strengthen health system pharmacy strategy.
• 0:55
  I'm joined today by Josh Weiner,
• 0:57
  former CEO of DoseSpot and current CEO of
• 1:00
  Entera Health, as well as Kyle Kaiser, former
• 1:03
  CEO of Arrive Health and current board member
• 1:06
  and senior advisor
• 1:08
  to Entera
• 1:09
  Health. Both bring deep experience across e prescribing,
• 1:13
  pharmacy benefit visibility,
• 1:15
  and point of care clinical decision support.
• 1:18
  Josh, Kyle, it's a pleasure to be speaking
• 1:20
  with you today on behalf of Becker's Healthcare
• 1:23
  Podcast.
• 1:24
  Great to be here. Thanks for having us,
• 1:26
  Rich. Before we dive in, tell me a
• 1:28
  little bit about Entera Health. Today's a big
• 1:30
  day for you.
• 1:31
  It is. It's a huge day.
• 1:34
  We,
• 1:36
  we are now forming
• 1:38
  a brand new organization
• 1:40
  that is built on decades
• 1:43
  of experience
• 1:44
  on all these topics that we'll explore today.
• 1:48
  Our
• 1:49
  company is Entera
• 1:50
  Health.
• 1:51
  It's the combination
• 1:53
  of Arrive Health and
• 1:55
  DoseSpot.
• 1:57
  And we are putting
• 1:59
  these two organizations
• 2:02
  together
• 2:03
  in pursuit
• 2:04
  of
• 2:05
  one platform
• 2:07
  for medication
• 2:08
  affordability
• 2:09
  and
• 2:10
  access.
• 2:11
  Yeah. I think
• 2:12
  the important point too that we're bringing together
• 2:15
  is,
• 2:16
  it's kind of the best of breed in
• 2:19
  both companies coming together is that we took
• 2:21
  what DoseSpot had established, which is a market
• 2:24
  leadership
• 2:25
  around,
• 2:27
  affordability content, around patient
• 2:30
  capabilities and deprescribing capabilities and and medical benefit
• 2:33
  eligibility, and we're now bringing that together with,
• 2:37
  our
• 2:38
  Arrive Health's market leadership
• 2:40
  in,
• 2:41
  in real time benefit and EPA and and
• 2:43
  then network reach that that provides. And those
• 2:46
  two things together create really a paradigm shifting
• 2:49
  opportunity,
• 2:50
  for the combined platform.
• 2:52
  So as a provider who prescribes and a
• 2:54
  patient who gets prescriptions, thank you in advance
• 2:57
  for the incredible work you're gonna be doing.
• 2:59
  It's sounds exciting.
• 3:01
  So based on your experience,
• 3:03
  where do you see the most common breakdowns
• 3:05
  between a provider
• 3:07
  prescribing
• 3:08
  and a patient
• 3:09
  getting the medication?
• 3:11
  How do you think those gaps impact health
• 3:13
  system performance
• 3:15
  and maybe even patient trust?
• 3:18
  You know, this is, it's gonna be a
• 3:20
  little bit like quoting the song lyrics of
• 3:22
  your favorite songwriter to your favorite songwriter, answering
• 3:24
  this question to you, Rich. But the problem
• 3:27
  still exists that providers have, limited visibility to
• 3:30
  price at 20 here. And I think where
• 3:32
  we've advanced that work over the last ten
• 3:35
  years as Arrive is that, you know, insurance
• 3:38
  pricing is much more visible and capable and
• 3:40
  and can be delivered in a quality high
• 3:42
  quality way for providers that's meaningful decision support
• 3:44
  now.
• 3:45
  But the way you pay for medications is
• 3:47
  not limited to just insurance pricing anymore. So
• 3:49
  being able to extend
• 3:51
  the capabilities
• 3:52
  at the point of care to include things
• 3:54
  that are more representative of what the patient
• 3:57
  faces is part of the goal. Is is
• 3:59
  how do you turn decision support
• 4:01
  not just from a real time benefit perspective,
• 4:04
  so meaning, you know, how do we generate
• 4:06
  an insurance price, but now how do you
• 4:08
  make real time benefit look like a real
• 4:10
  patient experience? And and all the ways you
• 4:12
  could pay and and what all those pharmacy
• 4:15
  options could be and do it in a
• 4:17
  way that is, here's where I'm quoting my
• 4:19
  favorite songwriter,
• 4:21
  fewer clicks, not more clicks, easier, not harder,
• 4:23
  and right every time.
• 4:25
  So so we're continuing on that scene. What
• 4:27
  role can health systems play in medication affordability
• 4:32
  and access?
• 4:34
  We,
• 4:35
  we see a a big opportunity
• 4:39
  grounding ourselves in what is the patient experience
• 4:44
  that you all as health system
• 4:47
  leaders are delivering or want to deliver
• 4:51
  in the in the future.
• 4:53
  And
• 4:54
  so
• 4:55
  you can provide patients with with the financial
• 4:58
  transparency. You can provide patients
• 5:01
  on their mobile device with an option
• 5:04
  to get the med delivered or picked up
• 5:07
  how and where they they want to, and
• 5:10
  there's a a continuity
• 5:12
  that's possible there. That's why health systems
• 5:14
  are so incredible at the work that they
• 5:17
  do. It's to provide continuous
• 5:19
  care
• 5:20
  from a to z and back to a
• 5:22
  again.
• 5:23
  And so we want to give you,
• 5:26
  and pay give everybody in the system the
• 5:29
  data that they need
• 5:31
  to get the meds that they that they
• 5:32
  need. Affordability
• 5:33
  is is one of the biggest barriers. We
• 5:35
  we can we can address that from an
• 5:37
  experience perspective.
• 5:39
  Yeah. The reality is that the the burden
• 5:41
  often falls on the provider either way.
• 5:45
  And or the provider organization, either way. Because
• 5:48
  the first call the patients wanna make when
• 5:49
  they have questions about their meds is to
• 5:50
  their provider because that's where they've established trust,
• 5:53
  and that's where the most trust resides in
• 5:55
  the value chain.
• 5:57
  And so providers are going to be answering
• 5:59
  those questions one way or another from patients.
• 6:02
  Our goal is to give them the tools
• 6:03
  and the right data to make sure that
• 6:05
  they can do that efficiently.
• 6:06
  They can do it in ways that help,
• 6:08
  improve continuity of care for the health system
• 6:10
  overall because that's where, you know, finding the
• 6:12
  right pharmacy and, you know, more often than
• 6:15
  not, that's gonna be the health system's pharmacy
• 6:16
  if if we're putting the right tools in
• 6:18
  place,
• 6:20
  is is part of the goal. It's how
• 6:21
  you start to turn that, what's today an
• 6:24
  administrative burden into
• 6:26
  a meaningful business opportunity for the health system
• 6:29
  and better patient outcomes.
• 6:31
  So let's talk a little bit about transparency
• 6:34
  to patients
• 6:35
  and putting patients at the center of this
• 6:37
  conversation.
• 6:39
  So if I'm a patient and you're
• 6:42
  prescribing for me,
• 6:44
  I need to know how much it's gonna
• 6:46
  cost me.
• 6:47
  But I also need to know that
• 6:49
  the prescription and the way it's being prescribed
• 6:52
  and where it's being prescribed is in my
• 6:54
  best interest.
• 6:56
  What type of fidelity
• 6:58
  will you have to ensure that?
• 7:00
  But in the spirit of reducing
• 7:03
  clicks
• 7:04
  and
• 7:05
  making the the holes
• 7:07
  you know, the often the best technology is
• 7:10
  the technology that we can't
• 7:12
  see, and I think that's the promise
• 7:15
  of some of these Agentic
• 7:18
  AI prototypes is that we're not even engaging
• 7:21
  in the technology.
• 7:22
  And that flies in the face of an
• 7:24
  addictive
• 7:25
  gamification
• 7:26
  app. So
• 7:27
  I can see the argument both ways, Rich.
• 7:31
  Yeah. I think it's,
• 7:33
  I almost wanna expand the definition to incentives.
• 7:35
  Right? Because when you think about gamification,
• 7:38
  the folks who use gamified tools are the
• 7:40
  not the ones that you need to engage
• 7:42
  with to drive down health care costs and
• 7:43
  improve outcomes. The you know, it's like the
• 7:45
  eighty twenty rule, and you're you're gonna engage
• 7:47
  with the the least
• 7:49
  sick and the least in need. And to
• 7:51
  drive a better outcome, you've got to engage
• 7:53
  with the folks that aren't ever going to
• 7:55
  engage with the Gamify tool.
• 7:57
  And what I think
• 7:58
  is exciting about the pharma value chain generally
• 8:02
  is formulary's
• 8:03
  cost complexity
• 8:05
  is its own form of gamification. And so
• 8:07
  how do we bring those
• 8:09
  collective incentives
• 8:10
  to bear for the most,
• 8:12
  in need patient population? Because that's where you
• 8:14
  can drive a big impact on cost and
• 8:16
  complexity.
• 8:17
  So probably one of the most brilliant minds
• 8:20
  in health care innovation three of us know
• 8:22
  and most of the people listening will have
• 8:24
  heard of, Kimberly Mueller, who's the vice chancellor
• 8:27
  for innovation and biotechnology
• 8:29
  at University of Colorado,
• 8:30
  is
• 8:31
  frequently quoted as saying that healthcare is over
• 8:34
  innovative
• 8:35
  and under transformed.
• 8:38
  What are your thoughts?
• 8:40
  I I,
• 8:41
  as you know, strongly agree with that perspective.
• 8:44
  And and part of it is because the
• 8:46
  real work
• 8:48
  is not flashy. The real work is not
• 8:51
  high sizzle technology often. It's dish digging. It's
• 8:55
  how do you build the right connectivity
• 8:57
  to the right workflows
• 8:58
  to meet the right users where they are,
• 9:00
  both patients, providers, and care team. And and
• 9:03
  that's that's been a lot of the work
• 9:05
  of of both of our organizations over the
• 9:08
  last many years.
• 9:10
  And and I think the mentality,
• 9:12
  you know, that sort of blue collar mentality
• 9:15
  of willing to roll your sleeves up and
• 9:16
  do the work to integrate in the right
• 9:17
  places and to get the right data integrations
• 9:19
  and to to get to the right patients
• 9:21
  in the right ways
• 9:23
  is absolutely the approach. Because that's
• 9:25
  that's what it takes for transformation,
• 9:28
  right, is to actually do the unglamorous
• 9:30
  parts of
• 9:32
  connecting the these legacy systems into new capabilities
• 9:36
  and and driving a different outcome.
• 9:38
  So Kyle, Josh,
• 9:40
  as two leaders
• 9:41
  in health care technology and as a provider,
• 9:45
  can I get you to commit
• 9:47
  on the record
• 9:49
  that entera health
• 9:50
  will be easier not harder,
• 9:53
  path of least resistance, fewer clicks not more
• 9:55
  clicks, and bulletproof right?
• 9:58
  I hereby make that commitment.
• 10:00
  Considering we were born out of the Care
• 10:03
  Innovation Center there in on the Anschutz campus,
• 10:06
  and that was
• 10:07
  the that was the bible. That's always the
• 10:09
  aspiration.
• 10:10
  Awesome. Well, Josh, Kyle, thank you both for
• 10:12
  your time today. I'm excited to see what
• 10:15
  Arrive Health and DoseSpot do together as in
• 10:18
  Terra Health.
• 10:19
  Thank you. Thank you. This is it. Take
• 10:21
  care.